skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease

Nature reviews. Nephrology, 2022-01, Vol.18 (1), p.38-55 [Peer Reviewed Journal]

2021. Springer Nature Limited. ;Springer Nature Limited 2021. ;ISSN: 1759-5061 ;EISSN: 1759-507X ;DOI: 10.1038/s41581-021-00488-2 ;PMID: 34616096

Full text available

Citations Cited by
  • Title:
    Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease
  • Author: Baek, Judy ; He, Chenchen ; Afshinnia, Farsad ; Michailidis, George ; Pennathur, Subramaniam
  • Subjects: Cardiovascular disease ; Data analysis ; Diabetes ; Fatty Acids ; Humans ; Kidney diseases ; Lipid Metabolism ; Lipidomics ; Lipids ; Mass spectrometry ; Metabolism ; Metabolites ; Quality control ; Quality standards ; Renal Insufficiency, Chronic - etiology ; Renal Insufficiency, Chronic - metabolism ; Scientific imaging ; Triglycerides
  • Is Part Of: Nature reviews. Nephrology, 2022-01, Vol.18 (1), p.38-55
  • Description: Dyslipidaemia is a hallmark of chronic kidney disease (CKD). The severity of dyslipidaemia not only correlates with CKD stage but is also associated with CKD-associated cardiovascular disease and mortality. Understanding how lipids are dysregulated in CKD is, however, challenging owing to the incredible diversity of lipid structures. CKD-associated dyslipidaemia occurs as a consequence of complex interactions between genetic, environmental and kidney-specific factors, which to understand, requires an appreciation of perturbations in the underlying network of genes, proteins and lipids. Modern lipidomic technologies attempt to systematically identify and quantify lipid species from biological systems. The rapid development of a variety of analytical platforms based on mass spectrometry has enabled the identification of complex lipids at great precision and depth. Insights from lipidomics studies to date suggest that the overall architecture of free fatty acid partitioning between fatty acid oxidation and complex lipid fatty acid composition is an important driver of CKD progression. Available evidence suggests that CKD progression is associated with metabolic inflexibility, reflecting a diminished capacity to utilize free fatty acids through β-oxidation, and resulting in the diversion of accumulating fatty acids to complex lipids such as triglycerides. This effect is reversed with interventions that improve kidney health, suggesting that targeting of lipid abnormalities could be beneficial in preventing CKD progression.
  • Publisher: England: Nature Publishing Group
  • Language: English
  • Identifier: ISSN: 1759-5061
    EISSN: 1759-507X
    DOI: 10.1038/s41581-021-00488-2
    PMID: 34616096
  • Source: AUTh Library subscriptions: ProQuest Central
    MEDLINE

Searching Remote Databases, Please Wait